NCT05743621 2025-11-21
Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate Cancer
Weill Medical College of Cornell University
Phase 1 Recruiting
Clinical Trials
3 trialsNCT02980029 2024-10-22
TVB 2640 for Resectable Colon Cancer Other Resectable Cancers; a Window Trial.
University of Kentucky
Phase 1 Terminated
NCT02223247 2017-08-14
A Phase 1, First-In-Human Study of Escalating Doses of Oral TVB-2640 in Patients With Solid Tumors
Sagimet Biosciences Inc.
Phase 1 Completed